We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
-7.09%
1 Year Est. Return
+9.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.86M
AUM Growth
-$188M
Cap. Flow
-$186M
Cap. Flow %
-1,882.29%
Top 10 Hldgs %
17.98%
Holding
708
New
41
Increased
5
Reduced
51
Closed
611

Top Buys

Rank Stock Value
1
ACVA icon
ACV Auctions
ACVA
+$194K
2
RPD icon
Rapid7
RPD
+$183K
3
EFC
Ellington Financial
EFC
+$181K
4
SAN icon
Banco Santander
SAN
+$159K
5
OSCR icon
Oscar Health
OSCR
+$155K

Top Sells

Rank Stock Value
1
EXLS icon
EXL Service
EXLS
+$830K
2
DK icon
Delek US
DK
+$724K
3
AVGO icon
Broadcom
AVGO
+$669K
4
ITRI icon
Itron
ITRI
+$666K
5
EAT icon
Brinker International
EAT
+$649K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.83%
2 Technology 15.87%
3 Healthcare 10.98%
4 Industrials 10.86%
5 Real Estate 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEN icon
51
Wendy's
WEN
$1.45B
$97.8K 0.99%
+14,068
New +$108K
CFFN icon
52
Capitol Federal Financial
CFFN
$1.07B
$95.5K 0.97%
13,388
-2,472
-16% -$17.6K
GSM icon
53
FerroAtlántica
GSM
$635M
$95.1K 0.97%
23,094
-32,298
-58% -$156K
RWT
54
Redwood Trust
RWT
$630M
$94.9K 0.96%
+16,910
New +$98K
WEAV icon
55
Weave Communications
WEAV
$541M
$92K 0.93%
19,921
+321
+2% +$1.87K
CYRX icon
56
CryoPort
CYRX
$819M
$91.2K 0.93%
11,014
-348
-3% -$3.14K
CLF icon
57
Cleveland-Cliffs
CLF
$5.28B
$91K 0.92%
10,773
-4,454
-29% -$51K
QS icon
58
QuantumScape Corp
QS
$3.72B
$88.5K 0.9%
13,864
-3,288
-19% -$27.3K
JMIA
59
Jumia Technologies
JMIA
$778M
$85.9K 0.87%
12,454
-14,780
-54% -$149K
ORGO icon
60
Organogenesis Holdings
ORGO
$345M
$84.4K 0.86%
35,622
-27,567
-44% -$95.5K
EGAN icon
61
eGain
EGAN
$179M
$83.2K 0.84%
10,550
-8,825
-46% -$85.2K
NOK icon
62
Nokia
NOK
$59.3B
$82.9K 0.84%
+10,307
New +$75.7K
RILY icon
63
BRC Group Holdings
RILY
$284M
$81.6K 0.83%
11,149
-43,619
-80% -$325K
UGP icon
64
Ultrapar
UGP
$6.71B
$80K 0.81%
14,523
-37,357
-72% -$181K
TIGR
65
UP Fintech Holding
TIGR
$860M
$79.9K 0.81%
12,686
-12,574
-50% -$102K
BLMN icon
66
Bloomin' Brands
BLMN
$723M
$78.4K 0.8%
14,511
-44,092
-75% -$282K
GENI icon
67
Genius Sports
GENI
$1.78B
$78.3K 0.79%
+17,672
New +$126K
BSBR icon
68
Santander
BSBR
$40.5B
$77.7K 0.79%
+13,107
New +$83.4K
LYG icon
69
Lloyds Banking Group
LYG
$88B
$73.6K 0.75%
+14,629
New +$80.3K
PTON icon
70
Peloton Interactive
PTON
$2.75B
$72.5K 0.74%
16,899
-38,986
-70% -$190K
TTEC icon
71
TTEC Holdings
TTEC
$100M
$71.4K 0.72%
+28,574
New +$81.8K
STLA icon
72
Stellantis
STLA
$16.7B
$71.2K 0.72%
+10,037
New +$84.1K
SPT icon
73
Sprout Social
SPT
$494M
$71K 0.72%
+12,449
New +$95.9K
OPEN icon
74
Opendoor
OPEN
$4.32B
$69.5K 0.71%
+14,855
New +$80K
ARHS icon
75
Arhaus
ARHS
$1.07B
$69K 0.7%
10,178
-9,181
-47% -$83.4K

Similar funds

PharVision Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, PharVision Advisers held 708 positions worth $9.86M, down 95% from $198M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

PharVision Advisers withdrew a net $186M in Q1 2026, closing 611 positions and reducing 51 holdings. Its most notable exit was EXL Service, an estimated $830K position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

Against the trend, PharVision Advisers opened a new position in ACV Auctions worth $125K.

  • PharVision Advisers's largest Q1 2026 buy was ACV Auctions: 29,579 shares worth $125K.
  • PharVision Advisers added most to Embecta in Q1 2026, an estimated $48.4K increase.
  • PharVision Advisers's biggest Q1 2026 reduction was Herbalife, cutting an estimated $621K.
  • PharVision Advisers fully exited EXL Service in Q1 2026, selling an estimated $830K.
  • PharVision Advisers's ten largest holdings make up 18% of its $9.86M portfolio in Q1 2026.
  • PharVision Advisers opened 41 new positions and closed 611 in Q1 2026.
  • PharVision Advisers's portfolio value fell 95% quarter-over-quarter to $9.86M.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.